BNP Paribas Knock-Out TYL/ DE000PZ0W7Y8 /
26/07/2024 21:50:44 | Chg.+2.410 | Bid21:59:12 | Ask21:59:12 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
29.660EUR | +8.84% | 29.640 Bid Size: 368 |
29.750 Ask Size: 368 |
Tyler Technologies C... | 267.9589 USD | 31/12/2078 | Call |
GlobeNewswire
27/06
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
26/06
Basis Technologies Improves Planning Capabilities for Advertisers Through AI-Powered Media Automatio...
GlobeNewswire
18/06
Kite Realty Group Trust to Report Second Quarter 2024 Financial Results on July 30, 2024
Newsfile Corp
18/06
UneeQ Transforms Enterprise AI by Allowing Organizations to Leverage Their AI Investments and Create...
GlobeNewswire
17/06
TRULY® HARD SELTZER HEATS UP U.S. SOCCER PARTNERSHIP IN TIME FOR SUMMER KICK-OFF
GlobeNewswire
17/06
nCino Deploying Banking Advisor, a Generative AI Solution to Drive New Efficiencies in Financial Ins...
GlobeNewswire
14/06
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
13/06
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BE...
GlobeNewswire
13/06
Infinidat Wins Multiple Awards from Storage Magazine, UK at the 2024 Storries XXI
GlobeNewswire
12/06
United Lithium Announces Drill Results for Lithium Pegmatites D & E Confirming Strike Length of over...
GlobeNewswire
10/06
Silvaco to Announce First Quarter 2024 Financial Results and Provide Second Quarter and Full Year 20...
GlobeNewswire
07/06
AMERICAN SALARS FILES NI 43-101 TECHNICAL REPORT ON BLACKROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
05/06
Cipher Mining Announces Significant Upgrades to its Mining Fleet and Increases Target Hash Rate and ...
GlobeNewswire
05/06
VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibito...
GlobeNewswire
05/06
ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psori...